Allstadt SD, Rodriguez CO, Boostrom B et al. (2015) Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs. Journal of Veterinary Internal Medicine  29, 261–267

Marquardt TM, Lindley SES, Smith AN et al.(2019) Substitution of mitoxantrone for doxorubicin in a multidrug chemotherapeutic protocol for first-line treatment of dogs with multicentric intermediate- to large-cell lymphoma  Journal of the American Veterinary Medical Association  254, 236–242

Charney SC, Bergman PJ, McKnight JA et al. (2005) Evaluation of intracavitary mitoxantrone and carboplatin for treatment of carcinomatosis, sarcomatosis and mesothelioma, with or without malignant effusions: a retrospective analysis of 12 cases (1997–2002). Veterinary and Comparative Oncology 10, 171–181

Ogilvie GK ,Moore AS ,Obradovich JE et al.(1993)Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors. Journal of the American Veterinary Medical Association 202 ,1839–1844

Ogilvie GK ,Obradovich JE ,Elmslie RE et al. (1991)Efficacy of mitoxantrone against various neoplasms in dogs. Journal of the American Veterinary Medical Association 198 ,1618–1621